Market News
Lilly Amylin Combo Beats Tirzepatide In Obesity Trial
A mid-stage Lilly combo just outpaced high-dose tirzepatide on weight loss. The efficacy looks striking. The dropout numbers, and what...
30/09/2026
3 views